Vaccine hesitancy and public health

Vaccine hesitancy and public health

Vaccine hesitancy and public health

On this page

Vaccine Hesitancy - The Hesitation Spectrum

  • Vaccine hesitancy exists on a continuum from complete acceptance to outright refusal, influenced by factors of confidence, convenience, and complacency (3 Cs).
  • The Spectrum:
    • Acceptance: Unquestioning acceptance of all vaccines.
    • Hesitation/Caution: Voices concerns, seeks information, may delay or be selective about certain vaccines.
    • Refusal: Rejects all vaccines, often termed "anti-vaccine."

⭐ A major historical driver of vaccine hesitancy was a fraudulent 1998 study linking the MMR vaccine to autism. This claim has been definitively debunked by numerous subsequent studies.

Vaccine Hesitancy Continuum

Hesitancy Drivers - Why People Pause

📌 The "5 Cs" Model provides a framework for understanding key drivers.

  • Confidence: Lack of trust in vaccine safety, efficacy, or the healthcare system.
    • Fears about side effects, long-term effects, and novel technologies (e.g., mRNA).
    • Distrust in pharmaceutical companies or government agencies.
  • Complacency: Low perceived risk of acquiring a vaccine-preventable disease (VPD).
    • Belief that VPDs are not serious or that "natural" immunity is superior.
  • Calculation: Individual assessment of risks vs. benefits, often influenced by misinformation.
    • Emphasis on personal freedom and autonomy.

⭐ The fraudulent 1998 Lancet paper by Andrew Wakefield linking the MMR vaccine to autism remains a major source of hesitancy, despite being retracted and thoroughly discredited.

The 5C Model of Vaccine Hesitancy

Public Health Impact - The Ripple Effect

  • Resurgence of Vaccine-Preventable Diseases (VPDs):
    • Localized outbreaks of measles, mumps, and pertussis are increasingly common in communities with low vaccination rates.
  • Erosion of Herd Immunity:
    • When vaccination coverage drops below a critical threshold, the collective immunity that protects an entire population is compromised.
    • This puts vulnerable individuals at high risk:
      • Infants too young to be vaccinated.
      • Immunocompromised patients (e.g., chemotherapy, HIV).
      • Elderly individuals.
  • Economic Burden:
    • Significant costs from outbreak investigation, control measures, and treating the sick.

⭐ Measles has an R₀ of 12-18, requiring a herd immunity threshold of ~95% to prevent outbreaks. Even small drops in vaccination rates can lead to rapid community transmission.

US MMR Vaccination Coverage by State (2023-24)

Clinician Strategies - Trust & Talk Tactics

  • Build Trust: Use empathetic, non-judgmental, patient-centered language. Validate concerns before offering facts.
  • Motivational Interviewing (MI): Guide patients to their own conclusions about vaccination benefits. Ask open-ended questions to explore their reasoning.
  • Use the C.A.S.E. Method:
    • Corroborate: Acknowledge their concerns are valid.
    • About Me: Note your role as a trusted expert.
    • Science: Briefly explain the data.
    • Explain/Advise: Give a clear, strong recommendation.

⭐ A presumptive recommendation (e.g., "Your child is due for vaccines today") is significantly more effective at increasing acceptance than a participatory approach (e.g., "What do you want to do about shots?").

High‑Yield Points - ⚡ Biggest Takeaways

  • Vaccine hesitancy, a major public health threat, is driven by misinformation (e.g., debunked MMR-autism link), personal beliefs, and distrust.
  • It undermines herd immunity, increasing the risk of outbreaks of diseases like measles and pertussis.
  • This disproportionately affects vulnerable populations, including infants and the immunocompromised.
  • Effective physician response involves empathetic listening and addressing concerns with evidence-based information.
  • Motivational interviewing is a key strategy to build trust and encourage vaccination.

Practice Questions: Vaccine hesitancy and public health

Test your understanding with these related questions

A scientist in Chicago is studying a new blood test to detect Ab to EBV with increased sensitivity and specificity. So far, her best attempt at creating such an exam reached 82% sensitivity and 88% specificity. She is hoping to increase these numbers by at least 2 percent for each value. After several years of work, she believes that she has actually managed to reach a sensitivity and specificity much greater than what she had originally hoped for. She travels to China to begin testing her newest blood test. She finds 2,000 patients who are willing to participate in her study. Of the 2,000 patients, 1,200 of them are known to be infected with EBV. The scientist tests these 1,200 patients' blood and finds that only 120 of them tested negative with her new exam. Of the patients who are known to be EBV-free, only 20 of them tested positive. Given these results, which of the following correlates with the exam's specificity?

1 of 5

Flashcards: Vaccine hesitancy and public health

1/7

Strep pneumoniae polysaccharide vaccine in adults produces an Ig_____ response.

TAP TO REVEAL ANSWER

Strep pneumoniae polysaccharide vaccine in adults produces an Ig_____ response.

M

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial